CVS Caremark Wegovy Prior Authorization: How to Get Approved (and Stay Approved)

CVS Caremark Wegovy prior authorization requires your prescriber to show that you meet your plan's rules. Its standard policy has four paths: adult weight loss, teen weight loss, heart protection, and MASH. Adult weight-loss requests need a starting BMI of 30+, or 27+ with a weight-related condition, plus a six-month program before drug therapy.¹

First, confirm that your plan uses policy 4774-C. The Caremark name on your card does not establish your benefits or guarantee approval.²

Affiliate disclosure: Some links on this page are affiliate links, marked "sponsored." The RX Index may earn a commission if you use them, at no extra cost to you. You can use every checklist on this page without paying us or joining a telehealth service.

Does your card say Aetna? Start with our Aetna Wegovy prior authorization guide, because Aetna can use different rules. On Medicare? Go to our Medicare GLP-1 Bridge prior authorization guide.

The timing deserves a close look. If you take the Wegovy pill for weight loss, your first approval can end about the same day you first qualify to renew it. We'll show you the dates, and how to plan around them.¹³

Three things change your answer:

• Your plan has to cover Wegovy for the reason it is prescribed. A routine PA does not add an excluded benefit. Ask whether the issue is a true benefit exclusion, a drug-list restriction, or a missing clinical review before you give up.²
• Which Wegovy you take matters. The pen, the pill, and Wegovy HD fit different paths. For adult weight loss under this policy, the first approval lasts 8 months for the pen and HD, but only 6 months for the pill.¹
• Renewal is its own test. On the adult weight-loss path, you need at least 3 months on a steady maintenance dose and at least 5% weight loss, or maintenance of that initial loss.¹

Where are you stuck? Checking coverage · Getting approved · Waiting · Denied · Renewing

Get my Caremark Wegovy checklist →

Free · printable · no signup

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation. For this page, we opened Caremark's own rulebook, request form, contact pages, and outcome report on September 22, 2026. See what we verified ↓

You're not doing anything wrong. Caremark writes these rules for doctors' offices, not for patients. Here's the plain-English version.

Is prior authorization really what's stopping your Wegovy?

A "prior authorization required" message means a review is needed—not that Wegovy is already covered. "Not covered" can mean a drug-list restriction, a product mismatch, or a true benefit exclusion. Check the exact wording, or ask the pharmacy for its reject code, before your doctor files.²

A prior authorization (PA) is a request your doctor's office sends to prove you meet your plan's rules before the plan pays. CVS Caremark is a pharmacy benefit manager, or PBM. That's the company that runs the prescription side of your health plan. Caremark writes standard rules. Your employer or health plan picks which ones to use, and it can change them.²⁴

So first, figure out which problem you actually have.

Tip: Ask the pharmacy to check the claim for your exact prescription and give you the full rejection message, not just "insurance said no." A price estimate and a final paid claim are not the same thing. Pharmacy reject codes, explained →⁵²

Two free ways to check your coverage:

1. Your Caremark account. Log in at caremark.com or in the CVS Caremark app. Search the exact Wegovy product and strength, like "Wegovy 0.25 mg pen" or "Wegovy 1.5 mg tablet." Take a screenshot.⁶
2. Have someone check for you. Ro's free GLP-1 Insurance Coverage Checker asks your plan for you and sends a report. It shows whether the Wegovy pen is covered and whether prior authorization is required. You don't need a Ro membership. It can't check the Wegovy pill yet, and it doesn't file a PA. Ro advertises a $50 credit for new Ro accounts that later start care.⁷

Not sure if it's prior authorization or an exclusion? Get the answer without making the calls yourself. Check my Wegovy pen coverage free with Ro → (sponsored) Free · no membership needed · checks the Wegovy pen, not the pill

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, your preferred form (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to explore provider matches before you choose. For this Wegovy insurance request, stay with the FDA-approved Wegovy product your prescriber orders—not compounded semaglutide.⁸

What are the CVS Caremark Wegovy prior authorization requirements?

CVS Caremark's standard Wegovy rules (policy 4774-C) have four paths: adult weight loss, teen weight loss, heart protection for adults with a qualifying heart or artery history, and fatty liver disease (MASH) with scarring. Only the two weight-loss paths require six months of a weight-management program before the drug. Each path has its own proof and its own approval length.¹

We read the whole policy. Here it is in one table.

Source: CVS Caremark policy 4774-C, "Wegovy PA with Limit," checked September 22, 2026. Every path also calls for a reduced-calorie diet and increased physical activity. This is the public standard policy, not proof that your plan uses it.¹

The adult weight-loss path

You need three things:

• Age 18 or older.
• A starting BMI of 30 or more, or 27 or more plus at least one weight-related condition. BMI (body mass index) is a number that comes from your height and weight. At 5 feet 6 inches, a BMI of 30 is about 186 pounds. A BMI of 27 is about 167 pounds.
• Six months in a weight program before your first weight-loss drug. This rule gets its own section below.

Caremark gives high blood pressure, type 2 diabetes, and high cholesterol as examples of weight-related conditions. The policy writes "e.g." in front of them, so they're examples, not a full list. Your doctor documents your condition, and your plan decides whether the record meets its rule.¹

Already lost weight on another drug? Your starting BMI still counts.

This is good news for switchers whose plan uses this policy. Caremark tells its reviewers to use your BMI, and your weight-related conditions, from when you started weight-loss drug therapy. Say you were at a BMI of 32, dropped to 28 on another medicine, and now need Wegovy. The 32 is what counts for that baseline test. Your doctor needs the dated record, and the other rules still apply.¹

The teen path (ages 12 to 17)

Teens can only get the Wegovy pen on this path. No pill, no HD. They need the same 6-month program and a starting BMI at or above the 95th percentile for their age and sex. Renewal is gentler than it is for adults: a steady maintenance dose plus a drop in BMI, or maintenance of that initial drop. There's no 5% bar.¹

The heart-protection path

This path is for adults who've had one of these:

• A heart attack
• A stroke
• Artery disease in the legs (PAD) that causes symptoms. Caremark's proof is leg pain when walking plus an ankle-brachial index (ABI) under 0.85 — a simple test that compares blood pressure in your ankle and arm. A leg-artery procedure, or an amputation caused by artery disease, also counts.
• A coronary bypass, coronary stent procedure, or angioplasty

You also need a starting BMI of 27 or more.¹

Here's what makes this path different:

• No 6-month program rule.
• A 12-month approval.
• Renewal has no weight-loss test. You need the same heart history and a maintenance dose.

The catch: the first-request heart criteria exclude type 2 diabetes. Caremark's policy points people with type 2 diabetes and heart disease to Ozempic instead. You also need to be on standard heart medicines, like a statin or a beta-blocker, or have a documented clinical reason you're not.¹

Only your prescriber can decide whether this path fits you. Never ask anyone to add a diagnosis you don't have. Wegovy for heart disease: who qualifies? →

The fatty liver path (MASH)

MASH is a type of fatty liver disease with swelling and damage in the liver. This path is for adults with moderate-to-advanced scarring (stages F2 to F3) and no cirrhosis. A gastroenterologist or hepatologist (a stomach or liver specialist) has to prescribe Wegovy or be consulted. The scarring must be supported by a noninvasive disease assessment, such as elastography or MRE, or a past liver biopsy.¹

There's no BMI rule. It's pen only, not the pill or HD. Renewal needs a positive liver response that was achieved or maintained, such as lower liver enzymes (ALT), an improved fibrosis test, or less liver stiffness.¹

Wegovy's MASH use has accelerated FDA approval based on improvement in MASH and fibrosis. Continued approval may depend on a trial confirming clinical benefit.³

What Caremark adds on top of the FDA label

Caremark's policy starts by listing Wegovy's FDA-approved uses. Then it adds its own rules:

• The 6-month program before any weight-loss drug (weight paths only).
• No type 2 diabetes for the first request on the heart path.
• Proof on paper. Caremark marks the BMI, the conditions, the heart history, the liver scarring, and every renewal result "Documentation is required for approval."

One thing it doesn't add is step therapy. Caremark's standard Wegovy rules don't make you try cheaper drugs first. Your plan can have separate requirements, so ask for its step-therapy rule rather than assuming this PDF is the whole benefit.² Step therapy for Wegovy →

Build your Caremark Wegovy checklist

Use this worksheet with the records checklist. Print it, or copy it into your own notes. It does not submit a request or decide whether you qualify.

Your first small step: fill in the plan, the exact Wegovy product, and whether this is a first request or renewal. Then use the matching checklist below. You do not need every answer before you contact the office.

Go to my records checklist →

Free. No signup. Public policy reference: Caremark 4774-C, checked September 22, 2026. The renewal examples below are planning aids—not a coverage decision.

What counts as Caremark's 6-month weight program?

For both weight-loss paths, CVS Caremark wants at least six months in a program with a reduced-calorie diet, more physical activity, behavior change, and ongoing follow-up before weight-loss drug therapy. The policy does not require a paid brand-name program. Ask your plan which dated records it accepts. The heart and liver paths skip this six-month requirement.¹

Caremark's policy asks for a comprehensive weight management program with follow-up for "at least 6 months prior to using drug therapy." Here are records to ask your plan about—not a guaranteed acceptance list.

Records that may count:

• Doctor visits about your weight, with notes on eating, activity, and follow-up
• Dietitian or nutrition visits
• An employer or health-plan wellness program
• Counseling focused on weight
• Regular weigh-ins and activity check-ins written in your chart

Records that do not, by themselves, show the required program:

• An app you downloaded but didn't really use
• A program that started after your first dose
• Anything without dates

Your plan decides what it accepts. Match each part of the rule to a dated record rather than sending an unexplained stack of documents.

If you switched from another weight-loss drug, including one you paid cash for, the six months had to come before your first weight-loss drug. Look for records from that time.¹

If you don't have six months of records yet:

1. Look for older records first. Your regular doctor, dietitian, or previous weight program may have dated notes you do not have at home.
2. If you have not started a weight-loss drug, ask what program your plan accepts. September 22, 2026 to March 22, 2027 is six calendar months. That date example does not guarantee approval.
3. If you already take a weight-loss drug, do not assume six new months of notes will meet a rule that says "before" drug therapy. Ask the plan how it handles your case, and ask your prescriber about review or treatment options. Do not stop treatment just to try to reset the clock.
4. Ask your prescriber whether the heart or liver path truly fits you. Only if it really does.
5. If insurance will not pay, discuss an FDA-approved cash option with your prescriber. Prices are in the cost section. Paying cash does not erase the pre-treatment program rule for a later PA.¹

One hard rule: never backdate anything. Caremark's request form warns about penalties for knowingly false statements connected with government payment under False Claims Acts. Send accurate dates and records.⁹

Does Caremark treat the Wegovy pen, pill, and HD the same?

No. CVS Caremark's standard criteria list all three, but that does not mean your plan covers all three. For adult weight loss, the first approval lasts 8 months for the pen and HD but only 6 months for the pill. Each product must also fit the treatment path and quantity rules.¹

Renewals last 12 months on every path in the standard policy. These are approval lengths, not guarantees of a covered benefit. Source: Caremark policy 4774-C.¹

The pill: adults only, on the weight or heart path. Its first weight-loss approval is the shortest at 6 months; the heart path gets 12 months. Whether your plan's drug list includes the pill is a separate question, so search the exact tablet strength in your Caremark app.¹

Wegovy HD (7.2 mg): here's a snag we found. Caremark's rules include HD for adult weight loss, with an 8-month first approval. But on September 22, 2026, Novo Nordisk's coverage checker displayed a message saying insurance coverage was not yet available for the 7.2 mg dose. That message is not a determination of your specific plan's benefits. Ask Caremark to check the exact HD product before your doctor files. NovoCare's standard self-pay HD price is $399 per 28-day supply. A separate covered path exists for eligible Medicare Bridge members: CMS lists HD's product code, 0169-4572-14, in that program. The commercial-policy entry, the manufacturer checker, and the Bridge are three different sources—not one coverage answer.¹⁶¹⁰¹¹

Switching between the pen and the pill (from the FDA label): for an adult already taking the 2.4 mg pen, the labeled switch is to start the 25 mg pill one week after the last shot. From the 25 mg pill, the usual labeled switch is to the 2.4 mg pen the next day. The label also describes using 1.7 mg in certain cases, including poor tolerance of the 25 mg pill. These are prescriber-directed switches—not starting doses or instructions to switch yourself. Ask whether Caremark needs a new request for the new form.³

Caremark's quantity limits:

Caremark says the shorter 21-day and 25-day windows allow time for refill processing. They do not guarantee that your particular claim will pay on day 21 or day 25. Ask the pharmacy for the next payable fill date. And if the prescription names a different device than your plan expects, the claim can still need correction after a PA is approved. The FlexTouch pen contains four weekly doses, so it must not be treated as one single-dose pen.¹³

Wegovy pill vs. injection →

What does your doctor need to send, and how do they send it?

Your prescriber or an authorized agent sends the clinical CVS Caremark prior authorization. Caremark's request form warns that drug details alone may not be enough, so attach the records for your actual path. For a first adult weight-loss request, that means the starting BMI, any qualifying condition, and the pre-treatment program records—not just a prescription.⁹²

Your records checklist

Adult weight loss: first request

Adult weight loss: renewal

These are record-organizing suggestions, not new rules. Policy 4774-C does not say every weight must be taken in person or that every diagnosis must include a particular lab. Ask which records your plan accepts.¹⁹

The other paths, in short:

• Teen: a dated BMI-for-age chart and program records. Later, a BMI trend showing a drop or maintenance of the initial drop.
• Heart, first request: a hospital or procedure record showing the event, a dated BMI of 27+, your diabetes status, and your heart medicine list (or the reason you're not on them).
• Liver: the accepted noninvasive assessment or past biopsy showing F2–F3 scarring and a specialist's note. Later, records showing a positive response achieved or maintained.¹

Copy this message to your doctor's office

For the adult weight-loss path. For heart, liver, or teen treatment, use the matching records above.

Hi — my Wegovy prior authorization goes to CVS Caremark. Could you confirm which policy my plan uses and whether this is an initial request or renewal? For a first adult weight-loss request under policy 4774-C, please include my dated starting BMI, any qualifying weight-related condition, and the required program records from before weight-loss drug therapy. Could you attach those records when you submit? Caremark's form says drug information alone may not be enough. Please also tell me the date it was sent and any reference number. Thank you.

Where's the CVS Caremark Wegovy prior authorization form?

Two different papers get mixed up all the time:

• The criteria (policy 4774-C) explain the rules. You don't fill them out.
• The request form is what the office submits when that form applies. Caremark's published "Formulary Exception/Prior Authorization Request Form" has version code 106-37207A 081826.⁹

The form has a weight-loss section with nine questions. For Wegovy, here's what they ask, in plain English:

1. For renewals: Has the patient had 3 months at a steady maintenance dose? Lost at least 5%, or kept it off? (With dated weights from before and after.)
2. Is the BMI 30 or more?
3. Or is the BMI 27 or more, with a weight-related condition?
4. Were chart notes showing the BMI or condition sent to CVS Health? The form specifically asks whether these records were sent.
5. Was there a 6-month weight program before drug therapy?
6. Will Wegovy be used with a reduced-calorie diet and more activity?
7. For teens: Is the patient 12 to 17, with a BMI in the obesity range?

The form also asks renewal questions, like whether you've taken the drug in the last 120 days and whether a past plan approved it. And it has an urgent box. More on that in the timing section.⁹

Caremark also links state-specific forms for places like California, Florida, Illinois, Michigan, Minnesota, and Texas. The office should use the submission rules for your plan and state.²

How the office sends it

Caremark's main prior authorization lines are open Monday–Friday, 8 a.m.–6 p.m. Central. The FEP line is open Monday–Friday, 7 a.m.–9 p.m. Eastern. These are prescriber lines. As a member, call the number on your card. Checked September 22, 2026.²¹²

Medicare GLP-1 Bridge requests use a separate process administered by Humana—not the ordinary Caremark Part D line above. Use the Bridge PA guide or CMS provider instructions.¹¹

ePA means electronic prior authorization. The office answers Caremark's questions online through tools like CoverMyMeds or Surescripts, or inside its own records system. Caremark's form says, "Please submit prior authorization (PA) requests electronically via ePA." Its PA page lists only ePA and phone for most non-Medicare plans, with no fax. If your plan's own form or your denial letter lists a fax number, use that one.²

Can Ro file your Caremark Wegovy prior authorization for you?

Yes, for eligible adult Ro Body patients prescribed the Wegovy pen. Ro says its insurance team submits prior authorization paperwork when a plan requires it, and estimates about 2 to 3 weeks for its insurance process. Ro doesn't run insurance for the Wegovy pill. Membership is $39 for the first month, then as low as $74 a month with the annual plan paid upfront, or $149 month to month. Medication is billed separately.¹³¹⁴¹⁵

First, the honest part: if your own doctor will file it, start there. You don't need a new provider just because you heard the words "prior authorization."

If your office won't handle weight-loss paperwork, or you need a new clinician who offers that help, that's where Ro fits.

What Ro does (checked September 22, 2026):

• When prior authorization is required, Ro says its insurance concierge "fights for coverage and submits all paperwork on your behalf."¹³
• Ro estimates about 2 to 3 weeks for the insurance process. That is its process estimate, not a Caremark decision deadline.¹³
• If you're covered, Ro sends the prescription to your pharmacy. If you're not, your Ro provider suggests FDA-approved cash-pay options.¹³
• Ro's pricing page says its standard cash medication prices match LillyDirect, NovoCare, and TrumpRx. Membership is extra.¹⁴

Here's the catch. Ro doesn't run insurance for the Wegovy pill. Only the Wegovy pen, the Zepbound pen, and Ozempic go through Ro's insurance team.¹³ If getting the pill covered by Caremark is your goal, your own doctor is the better path, so take the checklist above with you. More Wegovy pill insurance options →

Ro can handle the pen paperwork as part of its care program. If Caremark says no, your Ro provider can discuss FDA-approved cash-pay options, so you don't have to start the search over somewhere else. That does not change your plan's rules or guarantee a prescription.¹³

What it costs:

Ro Body is for adults. For a teen, work with a clinician who treats children and teens. For heart or liver treatment, confirm the clinician can manage that condition before paying for a weight-management program.¹⁵

Two terms to know before you sign up. First, the $39 refund is about medical eligibility, not about whether Caremark approves coverage. Second, the membership renews on its own. Cancel at least 48 hours before your renewal date to avoid the next charge. Apart from the stated eligibility refund, Ro's terms say paid membership fees are nonrefundable. You can be billed for membership even if you do not receive medication.¹⁴¹⁵

One Ro patient, quoted in Ro's own 2025 coverage report about switching to Zepbound, said "the team at Ro jumped into action and got the prior authorizations completed." (Published by Ro, our affiliate partner. The quote is about Zepbound, not a verified Caremark Wegovy approval. It is one person's experience and was not independently verified.)¹⁶

Does your doctor's office not handle weight-loss paperwork, or would you rather hand it off? See if Ro's Wegovy pen care fits me → (sponsored) Get started for $39, then as low as $74/month with the annual plan paid upfront, or $149 month to month. Medication is extra. Check availability in your state at signup. A clinician review is required, and your plan still makes the coverage decision.¹⁴¹⁵

More options: GLP-1 providers that accept CVS Caremark

How long does Caremark take, and how do you check the status?

There is no single Caremark Wegovy wait time for every plan. Ask when your PA was received, what is missing, and when a decision is due. Caremark's 2025 Indiana report averaged 0.27 days across all reported drugs—not just Wegovy—while NovoCare's general patient guidance says a PA can take up to 10 business days.¹⁷⁶

Here's what the sources say:

• Caremark's 2025 Indiana report: 35,097 initial PA requests across all reported drugs, with an average decision time of 0.27 days—about 6.5 hours. This is a historical report, not a promise for your case.¹⁷
• Caremark's FEP page: says electronic requests can be decided in "minutes to hours" and fax or phone requests can take "anywhere from 16 hours to 3 days." These are FEP process descriptions, not universal Caremark deadlines.¹²
• NovoCare: says a prior authorization "can take up to 10 business days." That general guidance does not replace your plan's deadline.⁶

Those figures measure different things. A doctor's preparation time, a plan's review time, and the time to fill a prescription are not one clock. That's why you track the case, not just the prescription.

Track your case with 4 details

What to ask (copy this)

To the doctor's office: "Did you submit my Wegovy prior authorization to CVS Caremark? On what day, and how? Were the chart notes attached? What's the reference number?"

To Caremark (use the number on your card): "Did you receive a Wegovy prior authorization for me? Is it complete? What's the status, and when is a decision due?"

Ask about the prior authorization case, not just the prescription. They're tracked separately. FEP Blue members can check status at fepblue.org, under "Manage My Prescriptions."¹²

The legal time limits for most job-based plans

These are federal ERISA group health plan rules for a request that must be approved before treatment or a fill—a pre-service claim. They are not one set of deadlines for every Caremark customer.¹⁸

Source: 29 CFR 2560.503-1. The initial clock starts when a claim is filed under the plan's reasonable filing rules, not only when every record arrives. Government plans, Medicare, Medicaid, and other plans can follow different rules; some state rules are faster. Read the notice, and ask the plan which deadline applies.¹⁸

If an urgent claim is missing information: under the ERISA rule, the plan generally must tell you within 24 hours, give you at least 48 hours to respond, and decide within 48 hours after your response or the response deadline, whichever comes first.¹⁸

About the urgent box: Caremark's form has one. Your prescriber uses it when waiting could seriously jeopardize your life, health, or ability to regain function, or when the applicable urgent-care standard is otherwise met. Under the ERISA rule, a treating physician's determination that the claim is urgent must be treated as urgent. It isn't a skip-the-line button.⁹¹⁸

How often does Caremark approve Wegovy?

In CVS Caremark's 2025 Indiana report, 3,833 of 5,083 Wegovy pen requests in the five disclosed rows were approved, or 75.4%. That covers one state, one year, and pens only, and it is not anyone's personal odds. Across all drugs in that report, appeals numbered 10.1% of denials, and 58.8% of reported appeals were approved.¹⁷

We used Caremark's own numbers, kept pending requests visible, and calculated each percentage from the reported request total.

Source: Caremark's 2025 Indiana Annual UR Report. We matched product codes to doses using NovoCare's product-code table, then did the math. Approved share means approved ÷ all requests, including pending requests. The five 11-digit codes, in dose order, are 00169452514, 00169450514, 00169450114, 00169451714, and 00169452414.¹⁷¹⁹

What stands out:

• Wegovy's 0.25 mg starter pen was the single most-requested product in the whole report. It had 2,755 requests, just ahead of Zepbound's starter pen (2,749).
• Wegovy's rows were denied 24.3% of the time. Across every drug in the report, the denial rate was 40.2%.
• Approval barely changed by dose, from 73.8% to 78.2%. Don't read much into that.
• The reported denial rows use the same category: "Does not meet clinical criteria." That broad reporting label does not tell us what an individual denial letter said. Ask for your actual reason and the specific rule. The denial section shows what to do with it.¹⁷¹⁸

What it can't tell you: the report covers one state (Indiana) and one year (2025), before the Wegovy pill was available. It only lists products appearing in the report's top-10 tables. It labels these as initial PA requests but does not separate people starting treatment from people seeking continued treatment. It is not your chance of approval.¹⁷

When does your approval end, and how do you renew it?

Under Caremark's standard policy, a first adult weight-loss approval lasts 8 months for the pen or HD and 6 months for the pill; teen weight-loss approval lasts 7 months, and heart and liver approvals last 12 months. Adult weight-loss renewal needs at least 3 months on a steady maintenance dose plus 5% weight loss or maintenance of that initial loss. The pill's shorter first approval leaves almost no room on the usual schedule.¹³

Here's the timing problem we found. It shows up when you line up two documents: Caremark's approval lengths and the FDA dose schedule.

The pen's standard dose schedule reaches its maintenance phase in week 17. The pill steps up every 30 days and reaches 25 mg on day 91. Adult weight-loss renewal needs 3 months at a steady maintenance dose. The pen can use 1.7 mg or 2.4 mg as maintenance, but the label lists weeks 13–16 at 1.7 mg as dose escalation—not automatically the start of the PA maintenance clock.³¹

A concrete example: suppose your approval and first dose both start September 22, 2026. Use March 22, 2027 as the example six-month end date and May 22, 2027 as the example eight-month end date. For this example, we count three calendar months at maintenance. Ask your plan how it counts the three-month requirement for your own request.

Our calculation, using Caremark policy 4774-C and the Wegovy label revised June 2026. These are hypothetical dates, not Caremark's promise to count months this way or a prediction that a renewal will be denied. Your letter supplies the real approval end date, and your office must confirm when your stable maintenance period began. If approval starts before the first dose, there is less time.¹³

Teen, heart, and liver renewals: these paths require maintenance dosing but do not state the adult weight-loss rule of three months at that dose. Teens must show a BMI drop or maintain the initial drop; heart renewal has no percentage-weight-loss test; MASH renewal needs a positive response achieved or maintained.¹

Wegovy HD: the label allows an increase to 7.2 mg only after at least four weeks tolerating 2.4 mg, when more weight reduction is clinically needed. Ask how your plan counts time at maintenance after a dose change and whether it needs a new request.³

What this means for you:

• Pen: the on-schedule example leaves 40 days. A dose delay can use most or all of that time.
• Pill: the example leaves just one day between completing three calendar months on 25 mg and the approval end date.

We don't know how your plan handles a pill renewal sent a few days short of 3 months. So plan ahead:

1. Find the end date on your approval letter and put it on your calendar today.
2. Book the weight check your plan accepts. For the example pen schedule, month 7 is a useful planning point. For the pill, contact the office around month 5 so it can plan submission and update the weight record when needed.
3. About a month before the end date, ask the office: "When will you send my renewal, and what happens if I'm a few days short of 3 months on my maintenance dose?"
4. Keep the date you actually started your maintenance dose. A fill record helps, but picking up medicine is not proof that you started taking that dose the same day.
5. Never change your dose schedule to fit the paperwork. Your prescriber sets the pace. Plan the paperwork around your dosing, not the other way around.

The 5% math, made simple: if you started at 240 pounds, 5% is 12 pounds. You'd need a dated record at or under 228 pounds if 240 pounds is the baseline your plan uses. You do not need a new 5% loss at every renewal; maintaining the initial loss can meet this rule.¹

Copy this renewal message

Hi — my Caremark Wegovy approval ends on [date]. For adult weight-loss renewal under policy 4774-C, Caremark asks for at least 3 months on a stable maintenance dose and at least 5% weight loss, or maintenance of the initial loss, with dated weights. Please confirm that my plan uses this rule. Could we record my weight at my next visit, and could you tell me when you plan to send the renewal?

If you haven't lost 5%: talk with your prescriber before the end date, and don't round numbers up. If you truly have the heart history for the heart path, that renewal has no percentage-weight-loss test. Only your prescriber can say whether that path fits, and the plan must review the proper request.¹

Renewal denials can be overturned, too. We found a real one, covered in the appeals section.

Why did Caremark deny your Wegovy, and what fixes it?

Start with the written reason, not the broad denial category in a public report. Ask which rule your plan applied, what evidence it considered, and what was missing. When a record was left out, ask whether to complete the existing case, correct the request, or appeal—and keep the appeal deadline in view.²¹⁸

Start with the written reason. Then find it here.

Decision aid assembled from the standard policy, Caremark's PA process, and federal claims rules. The notice for your own case determines which issue you need to address.¹²¹⁸

Fix it, ask for an exception, or appeal?

• Correct the record when something was missing, a date or weight was wrong, or the wrong product was requested. Ask whether to add it to the existing case, submit a corrected request, or use the appeal process.
• Ask for an exception when your plan added its own step or limit and your prescriber can show a real reason.
• Appeal when Caremark had your records and your prescriber disagrees with how the rules were applied.

Four things not to do

• Don't resend the same packet and hope.
• Don't treat "excluded" and "denied" as the same problem. An exclusion and a missing-record denial need different responses.
• Don't rely on a phone summary. Get the letter and the rule it cites.
• Don't let the deadline on the letter pass while you decide.

For denials from plans that don't use Caremark, see Why did my insurance deny Wegovy?

How do you appeal a Caremark Wegovy denial?

If CVS Caremark said no, you or your authorized representative can appeal using the steps in your denial letter. For an ERISA group health plan's pre-service claim, you must have at least 180 days to file; an urgent appeal must be decided within 72 hours, and a one-level standard appeal within 30 days. Other plan types can use different rules.¹⁸

The steps:

1. Read the letter. Find the reason, the rule it cites, the deadline, and where to send the appeal.
2. Ask for your claim file. For most job-based plans, you can ask for free copies of the documents used to decide your case.
3. Ask about a peer-to-peer review. That's a phone call between your prescriber and a Caremark clinical reviewer. Ask whether your plan offers one.
4. Build the appeal around the actual denial. Quote the rule your plan used. Under it, list the dated record that addresses it—or explain why your prescriber disputes the rule's application. Attach the records in that same order.
5. Keep proof of the date you filed, plus copies of everything.
6. After a final internal denial, read the external review section of your letter. Under the federal external-review process, you generally have 4 months after receiving the relevant denial notice to ask. Medical-judgment denials can qualify; a contractual benefit exclusion alone may not. Eligibility and procedures differ by plan and review system.²⁰

Do appeals work? Caremark's 2025 Indiana report lists 1,430 appeals and 14,114 denials—an appeal count equal to 10.1% of the denial count. Of the reported appeals, 58.8% were approved (841 of 1,430), and they took 4.18 days on average to decide. That's all drugs in one state, so it's not a promise. In that reported group, more appeals were approved than denied; 12 were still pending.¹⁷

A real case: In a New York external appeal, a patient with a self-funded CVS Caremark plan was denied a Wegovy renewal. Her weight had gone from 174 to 141 pounds, a 19% drop, which is well past the plan's 5% rule. The independent reviewer overturned the denial, finding that "the patient meets the criteria for continuing Wegovy." (New York Department of Financial Services, external appeal case 202208-152420, decided in 2022 under older criteria. This is a historical case, not a prediction for a new appeal.)²¹

Want the full letter, step by step? Use our How to appeal a Wegovy denial guide and our free GLP-1 appeal letter template. For an external review, use the instructions and contact listed in your final denial.

If the fix will take weeks, or your plan excludes Wegovy, FDA-approved cash-pay options can give you another path to discuss with your prescriber.

• Already have a prescriber? NovoCare Pharmacy is a manufacturer-supported cash-pay service fulfilled through licensed pharmacies. Prices are in the cost section.¹⁹
• Want a clinician and a cash plan in one place? Check eligibility for FDA-approved Wegovy care on Ro → (sponsored) Ro's published standard medication prices match NovoCare's; membership is extra.¹⁴
• Prefer to choose your own clinician? Explore clinician-led Wegovy options on Sesame Care → (sponsored) Medication and care costs depend on the option chosen.²²

What will Wegovy cost with Caremark, approved or not?

Once CVS Caremark approves Wegovy, you pay your share under the plan. Eligible people with commercial coverage can use Novo Nordisk's savings offer to pay as little as $25, with a maximum $100 discount per month. Without coverage, standard NovoCare self-pay prices are $349 for the pen after a qualifying $199 intro, $399 for HD, and $149 to $299 for the pill.²³¹⁹

If you're approved: the savings offer math

Novo's savings offer says you can "pay as little as $25, subject to a maximum savings of $100/month." The covered-copay offer is for eligible commercially insured patients whose plan covers Wegovy; government-program beneficiaries cannot use that copay offer.²³ A "month" means one box of 4 pens or one bottle of 30 tablets.

Example math based on the covered-commercial offer's $100 maximum discount and $25 target. A cost already below $25 does not rise to $25 because you skip the offer. Coinsurance means you pay a percent of the covered price instead of a flat copay.²³

The useful cutoff is $125. If your covered cost is between $25 and $125, the offer can bring it to $25 when you meet its terms. Above $125, the $100 maximum discount leaves you paying more than $25. Wegovy savings card guide →

Approved, but the price still looks wrong? Ask the pharmacy three things:

• "Is my approval attached to this exact prescription?"
• "What part of my plan is setting this price: a deductible, a copay, or coinsurance?"
• "Would a different in-network pharmacy change it?"

For the "covered but still expensive" problem, compare the claim message with the coverage-versus-PA table.

If you're not covered: FDA-approved cash prices

Checked September 22, 2026 against NovoCare's prices and pharmacy terms. These are medication prices, not the cost of getting a prescription. NovoCare lists Wegovy's manufacturer list price as $1,349.02 per package; that is not the cash offer shown here.¹⁰¹⁹²⁴

The offer dates matter. For the pharmacy's $199 injection intro, "new" means no previous Wegovy injection fill through the named NovoCare pharmacy program. The prescription must be written and received by December 31, 2026, and shipped by January 31, 2027. The discount applies to the first two qualifying 28-day fills.¹⁹

Already waiting on the earlier $149 offer for the 4 mg pill? The pharmacy terms still allow it for qualifying prescriptions written and received by August 31, 2026 and shipped by September 30, 2026. A new September prescription uses the $199 standard offer—not the expired new-entry promotion.¹⁹

Government insurance and cash pay are different questions. Medicare and other government-program members cannot use the commercial copay card, but NovoCare's separate self-pay terms allow eligible cash purchases outside insurance. You cannot seek insurance reimbursement or count that spending toward your plan's deductible or out-of-pocket limit.¹⁹

Ro, honestly: Ro's published standard medication prices match NovoCare's, but Ro adds its membership fee ($39 the first month, then as low as $74 a month with the annual plan paid upfront, or $149 month to month). If you already have a prescriber and choose the same standard cash offer, going directly through NovoCare avoids Ro's membership fee. Include any fees from your own clinician before comparing totals. Ro makes sense when you want the clinician, the paperwork, and a backup plan in one place.¹⁴¹⁹

On Medicare? Eligible Part D members can pay $50 per monthly supply through the separate Medicare GLP-1 Bridge, which runs from July 1, 2026 through December 31, 2027. That is not the commercial savings card. Medicare GLP-1 Bridge guide →¹¹²⁵

What about compounded semaglutide? It's a different category. Compounded drugs aren't FDA-approved, they aren't Wegovy, and your Wegovy approval doesn't cover them. The FDA does not review them for safety, effectiveness, or quality before they are marketed. For other cash-pay choices, see our cheapest GLP-1 without insurance guide.⁸

Switching from Zepbound, compounded semaglutide, another form, or another plan?

Caremark's standard policy tells reviewers to consider baseline BMI and weight-related conditions from the start of weight-loss drug therapy when switching. A new plan may use different criteria or require a new request. CVS has also announced an additional preferred Zepbound option starting October 1, 2026; the announcement does not tell every Wegovy user to switch.¹²⁶⁴

Answer the form's two switcher questions truthfully: "Has the patient received the drug in the last 120 days?" and "Was it approved by a prior plan?" If the answer is yes, say so and attach the old approval.⁹

About October 1, 2026: CVS announced on May 28, 2026 that Zepbound will return as "an additional preferred option" on its most common commercial drug lists, for plans that choose to cover weight-management drugs. Plans can still customize their coverage. If you're doing well on Wegovy, nothing in the announcement says you have to move. Your own plan can still change its benefits or drug list, so read any notice it sends.⁴

Is your Caremark card for Medicare, Medicaid, federal employees, or Aetna?

Different rules can apply to Medicare, Medicaid, FEP Blue, and Aetna. The Medicare GLP-1 Bridge has its own eligibility and PA process; it is not automatic coverage for every Medicare member. Do not send a standard commercial Caremark checklist when your plan or program uses a different one.¹¹²⁵¹²

The Bridge's weight rules differ from this page's commercial example. For adults in an eligible Part D plan, CMS uses BMI at the start of GLP-1 treatment:

For the blood-pressure criterion, CMS specifies a systolic reading above 140 or a diastolic reading above 90 despite two medicines. A prescriber must also confirm ongoing diet and activity measures. Type 2 diabetes, moderate-to-severe obstructive sleep apnea, and noncirrhotic MASH with F2–F3 scarring use the Part D pathway instead of the Bridge; prior paid GLP-1 coverage through Part D can also affect Bridge eligibility. If Wegovy is prescribed for heart-event risk reduction, that prescription goes through Part D. Use Medicare's eligibility page or the Bridge guide to check the full program rules.¹¹²⁵

Coverage isn't a medical yes: Wegovy safety basics

Getting CVS Caremark to cover Wegovy and deciding whether Wegovy is safe for you are two separate questions. The boxed warning concerns thyroid tumors seen in rodents; whether Wegovy causes these tumors in people is unknown. Do not use it with a personal or family history of medullary thyroid cancer, if you have MEN 2, or if you have had an allergic reaction to semaglutide or a Wegovy ingredient.³

A few more label points worth knowing:

• Using Wegovy with another semaglutide product or another GLP-1 receptor agonist is not recommended. This is separate from the formal contraindications above.
• For weight loss or heart-risk reduction, the label says to stop Wegovy when pregnancy is recognized and at least 2 months before a planned pregnancy. For MASH, the prescriber must weigh the risks and benefits; do not apply the weight-loss instruction to liver treatment without that discussion.
• Tell every care team you take Wegovy before surgery or deep sedation.
• Stop using Wegovy and seek medical advice right away for severe, lasting belly pain, which can be a sign of pancreatitis. Contact your prescriber about gallbladder symptoms or vomiting and diarrhea that will not stop. Get urgent help for trouble breathing or swelling of the face, lips, or throat. These are not all the warnings in the prescribing information.³

While you wait on Caremark: don't stretch doses, skip doses, or change your dose to make your supply last. Ask your prescriber for a safe plan instead.

Regulatory note: FDA's March 5, 2026 warning letter to Novo Nordisk concerned failures to report serious and unexpected adverse events as required. This was a safety-reporting compliance action; the letter does not establish that the medicines caused each reported event. The action concerns required safety reporting; it does not remove Wegovy's FDA approval.²⁷

What we actually verified (and what we couldn't)

We reviewed Caremark's public Wegovy criteria, its request form, PA contact pages, and 2025 Indiana report on September 22, 2026. We also checked NovoCare and Ro's published prices and terms. We cannot see your plan contract, private PA case, or final pharmacy claim. Your plan's written rules and decision explain what it applied; you can challenge an incorrect decision.

What we did:

• Compared Caremark's public policy 4774-C text with its displayed PDF pages. The retrieved copies did not show a consistent version label, so we do not claim that two URLs are identical or that one version applies to every plan. The criteria and approval lengths shown above were checked against the public policy.
• Read Caremark's Formulary Exception/Prior Authorization Request Form, version 106-37207A 081826.
• Checked Caremark's prior authorization contact page and its FEP prior approval page.
• Pulled Caremark's 2025 Indiana Annual UR Report and did the per-dose math ourselves.
• Read CVS Health's May 28, 2026 announcement about Zepbound.
• Checked the dosing section of the Wegovy FDA label (revised June 2026).
• Checked NovoCare's coverage, savings, self-pay, and pharmacy terms pages, and Ro's pricing, insurance, coverage-checker, and terms pages.
• Read New York DFS external appeal case 202208-152420, the federal claims rules, CMS/Medicare Bridge guidance, and FDA's compounding and safety-reporting material.

Provider-stated vs. what we verified

Sources: the linked policy, labeling, provider pages, prices, terms, and testimonial—not patient files or a test enrollment.^{1313141516619}

What we couldn't verify:

• Which version of the rules your plan uses, or whether your employer changed them
• Whether your employer adopted Caremark's October 1 change
• Your copay or deductible
• How Caremark handles a pill renewal sent a few days short of 3 months
• The exact wording of Caremark's ePA screens

Who we are: The RX Index is independent guidance for choosing your GLP-1 path. The RX Index Editorial Team created this guide to help you find the record or next step your request needs. We're not your insurer, your pharmacy, or your doctor, and this page isn't medical or legal advice. September 22, 2026 is the verification date—not a promise that a plan or price will stay the same.

What else should you know about CVS Caremark Wegovy prior authorization?

The same Caremark name can appear on plans with different benefits. Use these answers to narrow your next question, then check the exact policy and product attached to your own request.²

Does CVS Caremark require prior authorization for Wegovy?

Caremark's standard Wegovy policy (4774-C) is written as a prior authorization with quantity limits. Your plan can change it, so check the exact wording in your Caremark app or account.¹

What BMI does CVS Caremark require for Wegovy?

Under policy 4774-C, adult weight loss needs a starting BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. The initial heart path needs 27 or higher. The liver path lists no BMI rule. Teens need a BMI at or above the 95th percentile for age and sex.¹

Do I need type 2 diabetes to get Wegovy through Caremark?

No. Type 2 diabetes can count as a weight-related condition on the adult weight-loss path, but it isn't required. For the initial heart-protection request under policy 4774-C, it's the opposite: the policy excludes type 2 diabetes and points to Ozempic's separate indication.¹

Do I have to try other weight-loss drugs first?

Caremark's standard Wegovy rules don't include step therapy. Your plan can have separate requirements, so check its rules or your denial letter.¹²

How long does a CVS Caremark Wegovy approval last?

Under the standard policy, the first adult weight-loss approval lasts 8 months for the pen and HD or 6 months for the pill. Teen weight-loss approvals last 7 months, and heart and liver approvals last 12 months. Renewals last 12 months. Your plan can use different rules.¹

How do I renew my Wegovy prior authorization with CVS Caremark?

For adult weight loss under policy 4774-C, your doctor sends proof of at least 3 months on a steady maintenance dose and at least 5% weight loss, or maintenance of the initial loss, with dated weight records. Contact the office about a month before your approval ends; a pill renewal can need especially careful timing.¹

What is the CVS Caremark prior authorization phone number? Is there a fax?

For most non-Medicare plans, prescribers can call 1-800-294-5979 (Monday–Friday, 8 a.m.–6 p.m. Central) or use ePA at caremark.com/ePA. Caremark's page lists no fax for these plans. If your plan's form or your denial letter shows one, use that.²

How long does CVS Caremark take to approve Wegovy?

Ask your plan for the deadline on your case. The 2025 Indiana report averaged 0.27 days across all reported drugs; it is not a nationwide Wegovy turnaround promise. For ERISA pre-service claims, the standard maximum is generally 15 days with a qualifying extension possible; urgent rules generally require a decision within 72 hours.¹⁷¹⁸

Does CVS Caremark cover the Wegovy pill?

Caremark's standard rules include the pill for adult weight loss with a 6-month first approval, and heart protection with a 12-month first approval. Whether your plan's drug list includes it is a separate question. Search the exact tablet strength in your Caremark app.¹

Does CVS Caremark cover Wegovy HD (7.2 mg)?

Caremark's standard rules include HD for adult weight loss only, with an 8-month first approval. NovoCare's checker displayed a no-insurance-coverage message for HD on September 22, 2026. CMS separately includes the HD product in the Medicare Bridge for eligible members. Ask which benefit path applies and have the exact HD product checked.¹⁶¹¹

Do I have to fill Wegovy at a CVS pharmacy?

Not always. It depends on your plan's pharmacy network. Some plans let you use many pharmacies, and others steer you to certain ones or to mail order. Check the pharmacy finder in your Caremark account.²⁸

Will my Zepbound approval switch to Wegovy, or back after October 1?

Don't assume it will. Ask Caremark whether your plan moved your approval. If it didn't, your doctor files a new request under that drug's rules and answers the form's questions about recent use and past approvals.⁹²⁶

Can I use the Wegovy savings offer with Caremark?

Yes, when you meet the offer terms and your commercial plan covers the eligible Wegovy prescription. You may pay as little as $25, with a maximum discount of $100 per month. People on government plans, such as Medicare or Medicaid, cannot use that commercial copay offer.²³

What if my doctor won't submit the prior authorization?

Ask why. It could be missing records, an office policy, or a medical reason, and the next step depends on the answer. If it's an office policy, an eligible adult can consider a service with an insurance team, like Ro for the Wegovy pen. A new clinician still has to decide whether treatment fits, and the plan still decides coverage.¹³¹⁵

Is compounded semaglutide covered by my Wegovy approval?

No. Compounded drugs aren't FDA-approved and aren't Wegovy. The FDA doesn't review compounded drugs for safety, effectiveness, or quality before they're sold. A Wegovy approval covers Wegovy.⁸

Still not sure which GLP-1 program is right for you? Take our free matching quiz.

Find My GLP-1 Path →

Sources

Public sources checked September 22, 2026. Historical reports and cases are labeled with the year they describe. Calculations and decision tables are The RX Index's assembly of those sources, not private insurer data or tested approval results.

Wegovy® is a registered trademark of Novo Nordisk. CVS Caremark® is a registered trademark of CVS Health. This page is for general information only. It isn't medical, legal, or insurance advice.

Sources

1. CVS Caremark — Wegovy PA with Limit, policy 4774-C. Initial criteria, continuation, quantity limits, and approval duration.
2. CVS Caremark — Prior Authorization Information. Review types, contacts, ePA, and state forms.
3. Novo Nordisk — Wegovy FDA-approved prescribing information, revised June 2026. Indications, dosing, switching, contraindications, and warnings.
4. CVS Health — Expanded GLP-1 coverage options, May 28, 2026. Announced October 1, 2026 Zepbound change and plan customization.
5. Code names checked against New York State's official Medicaid billing guidance for codes 75, 76, and 79 and 2025 EPIC bulletin for code 70. These sources establish the code names, not Caremark-specific benefits or override rules.
6. NovoCare — Check your coverage for Wegovy. Public HD coverage message and general PA timing guidance.
7. Ro — Free GLP-1 Insurance Coverage Checker. Supported products, limits, and credit promotion.
8. FDA — Compounding and the FDA: Questions and Answers.
9. CVS Caremark — Formulary Exception/Prior Authorization Request Form, 106-37207A 081826.
10. NovoCare Pharmacy — Wegovy self-pay pricing.
11. CMS — Medicare GLP-1 Bridge information for providers, covering eligibility and product codes; and information for Part D plans, covering program dates and Humana central processing.
12. CVS Caremark — FEP Prior Approval Documents. FEP-specific forms, contacts, status lookup, and stated processing times.
13. Ro — Weight Loss Program and Insurance. Supported products and insurance assistance.
14. Ro — Weight Loss Program Pricing. Published membership and standard medication prices.
15. Ro — Terms of Use. Adult eligibility, recurring billing, cancellation, and nonrefundability.
16. Ro — 2025 GLP-1 Insurance Coverage Checker Report. Source of the Zepbound-switch testimonial; not used for current pricing.
17. CVS Caremark — 2025 Indiana Annual Utilization Review Report. Historical requests, decisions, pending cases, and appeals.
18. eCFR — 29 CFR 2560.503-1. ERISA claims, notice, records, urgency, and appeal rules.
19. NovoCare — Pharmacy terms. Operators, product codes, fill sizes, cash-pay restrictions, and exact promotional deadlines.
20. eCFR — 45 CFR 147.136. Internal appeals and external-review procedures.
21. New York Department of Financial Services — External appeal case 202208-152420, 2022.
22. Sesame — Online weight-loss program. Provider and program choices.
23. NovoCare — Wegovy savings offer. Commercial copay savings, limits, and eligibility.
24. NovoCare — Wegovy cost, coverage, and savings resources. Manufacturer list price per package.
25. Medicare.gov — Weight loss drugs. Bridge enrollment, eligibility, exclusions, and patient costs.
26. CVS Caremark — State of Tennessee plan information. Warning that PAs may not transfer to a new plan.
27. FDA — Novo Nordisk warning letter 717576, March 5, 2026. Adverse-event reporting compliance.
28. CVS Caremark — CalPERS information center. Example of plan-specific pharmacy network and drug-cost tools; use the tools for your own plan.